Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07490197 · ClinicalTrials.gov registry record

Acute Subdural Hematoma

A clinical trial, sponsored by Methodist Health System.

Recruiting
Registry status
100
Enrollment target

NCT07490197 is a clinical trial that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07490197 is actively recruiting participants, sponsored by Methodist Health System.

RECRUITING
Registry status
100 participants
Enrollment target

Study Summary

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

Interventions

  • OTHER Medical/Phenotype Data Collection Procedures & Data to be Collected

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-02
Est. Completion 2028-02

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT07490197

The ClinicalTrials.gov registry entry for NCT07490197 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Medical/Phenotype Data Collection Procedures & Data to be Collected is the first listed.

NCT07490197 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07490197 about?

NCT07490197 is a clinical study titled "Acute Subdural Hematoma". This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

What is the current status of trial NCT07490197?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-02. Estimated completion is 2028-02.

What interventions are being tested in trial NCT07490197?

The interventions under investigation include: Medical/Phenotype Data Collection Procedures & Data to be Collected (OTHER).

Who is sponsoring clinical trial NCT07490197?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.